Author

Arwa Alsubait

h-index 6 View on Semantic Scholar

We have 3 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

IKK16 and SGI1027 induce cytoplasmic vacuolization, and their combination with chemotherapy drugs can enhance the efficacy of cancer therapeutics

It is shown that combining paraptosis-inducing compounds with anti-cancer drugs can reduce the required overall dosage concentration while preserving therapeutic efficacy, potentially revolutionizing cancer treatment.

Arwa Alsubait, Bandar Alghanem, H. Ghadbane et al. · Cell Death & Disease · 0 citations

Jul 2026

Abstract A065: The Role of miR-100 in lung cancer cell line: Relevance to cancer biology and potential therapy

This study identifies a novel regulatory axis involving miR-100, ST6GALNAC4, and TXNDC11 in lung cancer and identifies Vorinostat as a promising candidate for drug repurposing in this context.

B. Alotaibi, Arwa Alsubait · Clinical Cancer Research · 0 citations

Review Open access Aug 2026

Nanoparticle-Enabled Biomaterials for Controlled Drug Delivery in Implantable and Wearable Devices

This review provides a comprehensive assessment of four major nanoparticle families—polymeric carriers, lipid-based vehicles, inorganic systems, inorganic systems, and hybrid composites—focusing on how their physicochemical properties govern drug encapsulation, release behavior, and tissue compatibility.

Z. Asiri, Abeer Mobarki, Sahar S. Alghamdi et al. · International Journal of Mol... · 0 citations